TRIANA BIOMEDICINES ANNOUNCES OVERSUBSCRIBED $120M SERIES B FINANCING TO ADVANCE ITS MOLECULAR GLUE DEGRADER PIPELINE

Reuters · 3d ago

Please log in to view news